Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 7, 2015; 21(1): 246-253
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.246
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.246
Table 1 Characteristics of patients who underwent hepatectomy for the treatment of hepatocellular carcinoma by portal vein invasion
| vp1-2(n = 73) | vp3-4(n = 10) | P value | |
| Host-related factors | |||
| Age (yr) | 60.1 ± 9.7 | 59.0 ± 10.5 | 0.790 |
| Gender (Male/Female) | 67/6 | 8/2 | 0.236 |
| Albumin (g/dL) | 3.88 ± 0.52 | 3.81 ± 0.45 | 0.698 |
| Indocyanine green retention rate at 15 min (%) | 17.1 ± 11.6 | 17.5 ± 11.3 | 0.977 |
| Liver cirrhosis | 31 | 6 | 0.295 |
| Treatment-related factors | |||
| Preoperative transarterial chemoembolization | 35 | 7 | 0.191 |
| Method of resection (Anatomical/Non-anatomical) | 65/8 | 9/1 | 0.927 |
| Operation time (min) | 296 ± 240 | 343 ± 387 | 0.735 |
| Blood loss (mL) | 2623 ± 1740 | 3886 ± 3390 | 0.538 |
| Blood transfusion | 29 | 4 | 0.941 |
| Positive surgical margin | 10 | 1 | 0.746 |
| Tumor-related factors | |||
| Alpha-fetoprotein (ng/mL) | 9006 ± 34819 | 11211 ± 27261 | 0.802 |
| Tumor size (mm) | 54.7 ± 33.8 | 62.6 ± 30.0 | 0.234 |
| Number of tumors (Single/Multiple) | 41/32 | 5/5 | 0.713 |
| Capsule (Present/Absent) | 57/16 | 8/2 | 0.890 |
| Bile duct invasion | 11 | 3 | 0.237 |
| Serosal invasion | 11 | 6 | 0.001 |
| Stage (UICC) | < 0.001 | ||
| I | 0 | 0 | |
| II | 59 | 0 | |
| III | 13 | 9 | |
| IV | 1 | 1 |
- Citation: Yamamoto Y, Ikoma H, Morimura R, Shoda K, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 2015; 21(1): 246-253
- URL: https://www.wjgnet.com/1007-9327/full/v21/i1/246.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i1.246